Clinical Trial Update: Empagliflozin in Renal Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial update of empagliflozin in renal transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Renal Insufficiency

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Oslo University Hospital | Conditions: Diabetes Mellitus, Renal Insufficiency | Phase 4 | Status: COMPLETED